Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2. acbr [Internet]. 2022 Dec. 23 [cited 2026 Sep. 17];6(6):993-1002. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/14979